Multidisciplinary management of acromegaly: a consensus

A Giustina, G Barkhoudarian, A Beckers… - Reviews in Endocrine …, 2020 - Springer
Abstract The 13th Acromegaly Consensus Conference was held in November 2019 in Fort
Lauderdale, Florida, and comprised acromegaly experts including endocrinologists and …

Preoperative medical treatment for patients with acromegaly: yes or no?

F Albarel, T Cuny, T Graillon, H Dufour… - Journal of the …, 2022 - academic.oup.com
Transsphenoidal surgery is the first-line treatment for acromegaly. However, several factors
can modify surgical remission rates, such as the initial hormone levels, the size and …

Biochemical control in acromegaly with multimodality therapies: outcomes from a pituitary center and changes over time

A Ghajar, PS Jones, FJ Guarda, A Faje… - The Journal of …, 2020 - academic.oup.com
Purpose To determine the prevalence of insulin-like growth factor-1 (IGF-1) normalization
with long-term multimodality therapy in a pituitary center and to assess changes over time …

Machine learning as a clinical decision support tool for patients with acromegaly

C Sulu, AB Bektaş, S Şahin, E Durcan, Z Kara… - Pituitary, 2022 - Springer
Objective To develop machine learning (ML) models that predict postoperative remission,
remission at last visit, and resistance to somatostatin receptor ligands (SRL) in patients with …

Preoperative medical treatments and surgical approaches for acromegaly: A systematic review

C Papaioannou, M Druce - Clinical Endocrinology, 2023 - Wiley Online Library
Objective Acromegaly is a condition characterized by an overproduction of growth hormone
which infers high morbidity and mortality if left untreated. The objective of this review is to …

Therapeutic effect of presurgical treatment with longacting octreotide (Sandostatin® LAR®) in patients with acromegaly

M Bolanowski, W Zgliczyński, J Sowiński… - Endokrynologia …, 2020 - journals.viamedica.pl
Introduction: The aim of this study was to assess the therapeutic effect and the safety of pre-
surgical treatment with long-acting octreotide in patients with acromegaly. Material and …

Remission of acromegaly after transsphenoidal surgery

F Sajjad, QA Siddiq - Journal of Neurosurgery, 2022 - thejns.org
TO THE EDITOR: We read the article by Micko et al. 1 with interest (Micko ASG, Keritam O,
Marik W, et al. Dumbbell-shaped pituitary adenomas: prognosti c factors for prediction of …

Economic and pharmaco-economic analysis of acromegaly treatment: a systematic review

M Kamusheva, Y Rusenova, S Vandeva… - Biotechnology & …, 2019 - Taylor & Francis
Acromegaly is a rare disease with significant social and economic burden considering both
main treatment patterns and concomitant diseases. The aim of this study was to present a …

Retrospektive multifaktorielle Datenanalyse von Akromegalie-Patienten nach mikrochirurgischer transsphenoidaler Operation hinsichtlich des Outcomes …

D Emmanouilidis - 2021 - tud.qucosa.de
Abstract (DE) Als Akromegalie wird die klinische Manifestation eines bestehenden GH-
Überschusses und des dadurch resultierenden erhöhten IGF-1-Spiegels bezeichnet. Die …

[PDF][PDF] Pituitary adenoma-aspects of outcome after surgical intervention

E Uvelius - 2021 - portal.research.lu.se
Disease of the pituitary may negatively affect patients in multiple ways. The present thesis
evaluates four aspects of surgical outcome in patient's presenting with pituitary adenoma …